Navigation Links
GBC Seeks Nominations for Region's Third Annual Bioscience Awards

BALTIMORE, Jan. 14 /PRNewswire-USNewswire/ -- The Greater Baltimore Committee is seeking nominations for the Third Annual Greater Baltimore Region Bioscience Awards to be held on Tuesday, March 18, 2008. Those interested in nominating a company or individual for an award, visit

The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience, and President's Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. Self-nominations are accepted and encouraged. Nominations will close on March 10, 2008.

"We want to make sure that the researcher with a marketable idea, the mid-sized medical device company and all in the region's bioscience industry know that we appreciate the contribution they are making to our economy," said Donald C. Fry, President and CEO of the Greater Baltimore Committee.

Judges for the awards are: Ravinder Dhallan, M.D./Ph.D., M.B.A., chairman and chief executive officer, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Aaron H. Heifetz, Ph.D., vice president business development, Cognate BioServices, Inc.; James Hughes, vice president research and development, University of Maryland, Baltimore; Shira Kramer, Ph.D., president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

For more information, contact Lisbeth Pettengill at the Greater Baltimore Committee, 410-727-2820 or email to

SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
2. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
3. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
4. Genoptix Reports Strong Financial Results For Third Quarter 2007
5. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
6. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
7. Carrington Reports Third Quarter 2007 Results
8. Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results
9. China Kangtai Cactus Biotech, Inc. Reports Third Quarter 2007 Financial Results
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results
Post Your Comments:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... 2016 A person commits a crime, and the ... track the criminal down. An outbreak of foodborne ... Administration (FDA) uses DNA evidence to track down the bacteria ... far-fetched? It,s not. The FDA has increasingly used a complex, ... foodborne illnesses. Put as simply as possible, whole genome sequencing ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):